“Atorvastatin with Lactobacillus rhamnosus supplementation Ameliorates Pathogenesis of High fat-High fructose diet induced non-alcoholic fatty liver disease in rats”, biolsciences, vol. 2, no. 2, pp. 240–250, Jun. 2022, doi: 10.55006/biolsciences.2022.2206.